Page last updated: 2024-09-04

torcetrapib and Carcinoma

torcetrapib has been researched along with Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dietz, JD; Hu, X; Keiser, J; Knight, DR; Loging, WT; Perry, DA; Smith, AH; Xia, C; Yuan, H	1

Other Studies

1 other study(ies) available for torcetrapib and Carcinoma

Article	Year
Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology, 2009, Volume: 150, Issue:5 Topics: Adrenal Gland Neoplasms; Aldosterone; Anticholesteremic Agents; Blood Pressure; Calcium Signaling; Carcinoma; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Intracellular Fluid; Models, Biological; Quinolines; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship	2009

Article

Year

Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition.

Endocrinology, 2009, Volume: 150, Issue:5

Topics: Adrenal Gland Neoplasms; Aldosterone; Anticholesteremic Agents; Blood Pressure; Calcium Signaling; Carcinoma; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Intracellular Fluid; Models, Biological; Quinolines; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship

2009